Location: Home
  • search
  • go
  • Relate News
  • 4/25/2025AstraZeneca China Announces Major Reorganization to Bolster Biopharma ...
  • 4/25/2025China's Fast-Track Drug Approvals Accelerating Access to Novel Therapi...
  • 4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
  • 4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
  • 4/25/2025Akeso's Ivonescimab Gains Second Approval in China
  • 4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
  • 4/25/2025China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...
  • 4/25/2025Cell Therapy to AI: How J&J Has Been Sourcing the Transformational Sci...
  • 4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...
  • 4/24/2025US Capital Crunch Pushes China Biotechs to Roundabout Financings (Phar...
  • 4/24/2025China Biopharma Tracker – March 2025 (PharmaDJ)
  • 4/24/2025Ascletis Challenges Lilly, Novo With Promising Oral GLP-1 Data
  • 4/24/2025Bayer Pharma Accelerates Growth in China with Breakthru Therapies and ...
  • 4/24/2025Merck's Gardasil Sales Plunge Amid China Market Turbulence
  • 4/24/2025LTZ Thera Secures $40M in Oversubscribed Series A+ to Advance FIC Im...
  • 4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
  • 4/23/2025China Accelerates Development of Multivalent Vaccines and Digital Immu...
  • 4/23/2025Global Pharma Feels 'Sense of Urgency' to De-Risk from China Amid Risi...
  • 4/23/2025Cheaper Chinese HPV Vaccines Turn Merck's Gardasil From Boom to Bust (...
  • 4/22/2025As US Decouples, China Strengthens Biotech Ties With Japan (The Diplom...
  • 4/22/2025China Broadens Healthcare Access: Foreign Doctors and Drug Import Refo...
  • 4/22/2025Sanofi and Cathay Capital Launch $275M Fund to Boost Chinese Drug Comm...
  • 4/22/2025VelaVigo Announces Second Out-Licensing Deal for a FIC BsAb
  • 4/22/2025GemPharmatech Establishes San Diego Facility Amid U.S. Crackdown on Ch...
  • 4/22/2025Hengrui Initiates Phase I Trial for Novel Obesity siRNA Drug HRS-5817 ...
  • 4/22/2025CDE Issues the List of Reference Formulations for GQCE Studies (91st B...
  • 4/22/2025Zai Lab's Repotrectinib sNDA Accepted by China NMPA
  • 4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...
  • 4/22/2025Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance
  • 4/22/2025China Approves New Indication of Opdivo for NSCLC
  • Page:9/770 Total number of articles:23098: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group